TMDX analyst estimates
TransMedics (TMDX) analyst ratings, the average price target and its range, and every firm's latest call.
TMDX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | Canaccord Genuity | TransMedics price target lowered to $94 from $95 at Canaccord | $94.00 |
| Oct 6, 2026 | Barclays | TransMedics initiated with an Overweight at Barclays | $120.00 |
| Aug 5, 2026 | Stifel Nicolaus | TransMedics price target lowered to $65 from $80 at Stifel | $65.00 |
| Aug 5, 2026 | Canaccord Genuity | TransMedics price target lowered to $95 from $124 at Canaccord | $95.00 |
| Aug 5, 2026 | Robert W. Baird | TransMedics price target raised to $122 from $120 at Baird | $122.00 |
| Aug 3, 2026 | Needham | TransMedics Group (TMDX) PT Lowered to $106 at Needham | $106.00 |
| Jul 28, 2026 | UBS | TransMedics initiated with a Neutral at UBS | $80.00 |
| Jul 6, 2026 | Evercore ISI | TransMedics price target lowered to $90 from $100 at Evercore ISI | $90.00 |
| Jun 18, 2026 | Stifel Nicolaus | TransMedics price target raised to $80 from $75 at Stifel | $80.00 |
| May 26, 2026 | Stifel Nicolaus | TransMedics price target lowered to $75 from $85 at Stifel | $75.00 |
| May 6, 2026 | Robert W. Baird | TransMedics price target lowered to $140 from $157 at Baird | $140.00 |
| May 6, 2026 | Stifel Nicolaus | TransMedics price target lowered to $85 from $130 at Stifel | $85.00 |
| May 6, 2026 | Piper Sandler | TransMedics price target lowered to $120 from $160 at Piper Sandler | $120.00 |
| May 6, 2026 | Canaccord Genuity | TransMedics price target lowered to $124 from $152 at Canaccord | $124.00 |
| May 6, 2026 | Needham | TransMedics price target lowered to $142 from $174 at Needham | $142.00 |
- 11 firms rate TMDX: 7 buy, 4 hold, 0 sell.
- The average price target is $99.62 from 8 analysts, from $65.00 to $122.00.
Updated 2026-11-02 23:11 UTC